However, obese individuals and those with malabsorption may require longer treatment periods and higher doses
Another is that GLP-1s didnt completely eliminate severe migraine pain, but the findings do suggest GLP-1s are associated with reduced migraine severity
In the first Phase 3 trial, participants on the highest dose lost an average of 29% of their body weight over about 16 months
Wegovy is a prescription weight-loss medication containing semaglutide, a GLP-1 receptor agonist
Speeds up muscle, tendon & ligament healing Reduces inflammation and chronic pain Strengthens gut lining for better digestion Improves post-surgery and injury recovery Supports healthy blood flow to damaged tissue Helps with nerve repair and mobility May protect against oxidative and toxin-related damage Sports injury recovery Post-surgery healing Tendonitis, ligament tears Chronic joint/muscle pain Gut disorders (GERD, IBS, leaky gut) Lost 40 lbs in 6 months
Many compounded semaglutide formulations require subcutaneous injection
